drugset / Trial / NCT04812860

A Study to Evaluate the Efficacy and Safety of HR18042 Tablets in the Treatment of Postoperative Pain of Impacted Tooth.

NCT04812860

Phase 2 Completed 187 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study was to evaluate the Efficacy and safety of HR18042 tablets for the Treatment of Post-surgical Pain After extraction of impacted tooth, find the optimal dose.

Timeline

Start
2020-12-08
Primary completion
2021-01-25
Completion
2021-01-25

Drugs

EvaluationDrugModalityDoseRoute
Subject HR18042 Unknown 100 mg Oral
Subject HR18042 Unknown 125 mg Oral
Subject HR18042 Unknown 200 mg Oral
Comparator Tramadol hydrochloride ER Unknown 100 mg Oral

Indications

No indication recorded.